Mark E. Cartwright

2.0k total citations
36 papers, 1.5k citations indexed

About

Mark E. Cartwright is a scholar working on Molecular Biology, Oncology and Small Animals. According to data from OpenAlex, Mark E. Cartwright has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Small Animals. Recurrent topics in Mark E. Cartwright's work include Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Mark E. Cartwright is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Mark E. Cartwright collaborates with scholars based in United States, United Kingdom and Bulgaria. Mark E. Cartwright's co-authors include George R. Lankas, Diane R. Umbenhauer, L. David Wise, Todd R. Pippert, Stacia Kargman, J. Frank, Denis Riendeau, Jillian F. Evans, Gary P. O’Neill and Joseph A. Mancini and has published in prestigious journals such as Gastroenterology, Carcinogenesis and Journal of Theoretical Biology.

In The Last Decade

Mark E. Cartwright

34 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark E. Cartwright United States	18	407	380	311	300	224	36	1.5k
Daniel F. Carr United Kingdom	24	213 0.5×	308 0.8×	252 0.8×	107 0.4×	333 1.5×	67	1.5k
Bruce D. Car United States	26	710 1.7×	547 1.4×	886 2.8×	50 0.2×	345 1.5×	56	3.9k
Juan Li China	25	136 0.3×	204 0.5×	585 1.9×	70 0.2×	133 0.6×	112	1.9k
Bin Zhao China	23	301 0.7×	163 0.4×	388 1.2×	71 0.2×	400 1.8×	97	1.5k
Monique Dumas France	19	288 0.7×	94 0.2×	273 0.9×	93 0.3×	90 0.4×	54	1.4k
Andreas Pahl Germany	32	591 1.5×	641 1.7×	1.2k 3.8×	57 0.2×	373 1.7×	105	3.5k
Janelle M. Hoskins United States	23	1.0k 2.6×	307 0.8×	805 2.6×	238 0.8×	160 0.7×	72	2.3k
David S. Loose United States	30	349 0.9×	126 0.3×	1.3k 4.2×	65 0.2×	239 1.1×	70	2.8k
Zsolt Tulassay Hungary	29	478 1.2×	402 1.1×	617 2.0×	54 0.2×	913 4.1×	127	3.5k
Allan Pont United States	19	268 0.7×	100 0.3×	448 1.4×	58 0.2×	205 0.9×	28	1.9k

Countries citing papers authored by Mark E. Cartwright

Since Specialization

Citations

This map shows the geographic impact of Mark E. Cartwright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Cartwright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Cartwright more than expected).

Fields of papers citing papers by Mark E. Cartwright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Cartwright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Cartwright. The network helps show where Mark E. Cartwright may publish in the future.

Co-authorship network of co-authors of Mark E. Cartwright

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Cartwright. A scholar is included among the top collaborators of Mark E. Cartwright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Cartwright. Mark E. Cartwright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boyer, David S., José Rivera, Steven D. Podos, et al.. (2021). Oral Administration of the Complement Factor D Inhibitor Danicopan (ALXN2040) in Preclinical Studies Demonstrates High and Sustained Drug Concentrations in Posterior Ocular Tissues for the Potential Treatment of Geographic Atrophy. Investigative Ophthalmology & Visual Science. 62(8). 187–187. 6 indexed citations

Phadke, Avinash, Viral Kansara, David S. Boyer, et al.. (2020). Ocular Pharmacokinetics and Safety of Suprachoroidal A01017, Small Molecule Complement Inhibitor, Injectable Suspension in Rabbits. Investigative Ophthalmology & Visual Science. 61(7). 3694–3694. 8 indexed citations

Marlor, Christopher W., Steven D. Podos, Craig B Struble, et al.. (2020). Ocular Tissue Distribution of the Complement Factor D Inhibitor Danicopan Following Oral Administration in Rabbits. Investigative Ophthalmology & Visual Science. 61(7). 4916–4916. 1 indexed citations

Higgins, John, Mark E. Cartwright, & Allen C. Templeton. (2012). Progressing preclinical drug candidates: strategies on preclinical safety studies and the quest for adequate exposure. Drug Discovery Today. 17(15-16). 828–836. 24 indexed citations

Deng, Yongqi, Zhiwei Yang, Gerald W. Shipps, et al.. (2012). Discovery of liver-targeted inhibitors of stearoyl-CoA desaturase (SCD1). Bioorganic & Medicinal Chemistry Letters. 23(3). 791–796. 15 indexed citations

Cartwright, Mark E., Joseph C. Fleishaker, Sedigheh Madani, et al.. (2010). Proof of Concept: A PhRMA Position Paper With Recommendations for Best Practice. Clinical Pharmacology & Therapeutics. 87(3). 278–285. 42 indexed citations

Bass, Alan, Mark E. Cartwright, Richard A. Morrison, et al.. (2009). Exploratory drug safety: A discovery strategy to reduce attrition in development. Journal of Pharmacological and Toxicological Methods. 60(1). 69–78. 50 indexed citations

Corboz, Michel R., Maria A. Rivelli, Garfield G. Mingo, et al.. (2006). α2-adrenoceptor agonists as nasal decongestants. Pulmonary Pharmacology & Therapeutics. 20(2). 149–156. 19 indexed citations

Lankas, George R., L. David Wise, Mark E. Cartwright, Todd R. Pippert, & Diane R. Umbenhauer. (1998). Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reproductive Toxicology. 12(4). 457–463. 237 indexed citations

10.

Lankas, George R., Mark E. Cartwright, & Diane R. Umbenhauer. (1997). P-Glycoprotein Deficiency in a Subpopulation of CF-1 Mice Enhances Avermectin-Induced Neurotoxicity. Toxicology and Applied Pharmacology. 143(2). 357–365. 155 indexed citations

11.

Umbenhauer, Diane R., George R. Lankas, Todd R. Pippert, et al.. (1997). Identification of a P-Glycoprotein-Deficient Subpopulation in the CF-1 Mouse Strain Using a Restriction Fragment Length Polymorphism. Toxicology and Applied Pharmacology. 146(1). 88–94. 89 indexed citations

12.

Cartwright, Mark E., et al.. (1996). Improved method for rhesus monkey or rat skin preparation and cryosectioning for topical or transdermal skin distribution studies. Experimental Dermatology. 5(1). 45–48.

13.

Kargman, Stacia, S. Charleson, Mark E. Cartwright, et al.. (1996). Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology. 111(2). 445–454. 400 indexed citations

14.

Storer, Richard D., Mark E. Cartwright, W. O. Cook, Keith A. Soper, & Warren W. Nichols. (1995). Short-term carcinogenesis bioassay of genotoxic procarcinogens in PIM^® transgenic mice. Carcinogenesis. 16(2). 285–293. 31 indexed citations

15.

Wise, L. David, et al.. (1994). Dietary two-generation reproduction study of thiabendazole in Sprague-Dawley rats. Food and Chemical Toxicology. 32(3). 239–246. 8 indexed citations

16.

Cartwright, Mark E., et al.. (1994). Von Kossa's Method for Renal Mineralization: Application for Multiple Specimens Using Capillary Gap Technology. Biotechnic & Histochemistry. 69(5). 257–262. 1 indexed citations

17.

Balena, R., et al.. (1993). The effects of three different demineralization agents on osteopontin localization in adult rat bone using immunohistochemistry. Histochemistry. 99(4). 295–301. 54 indexed citations

18.

Gould, R J, L W Schaffer, Raymond E. Gibson, et al.. (1992). Immunocytochemical localization of platelets in baboon hepatic sinusoids using monoclonal mouse anti-human platelet glycoprotein IIIa following induction of thrombocytopenia. Histochemistry and Cell Biology. 97(4). 355–360. 7 indexed citations

19.

Jaenke, Roger S., Bruce A. Cummings, & Mark E. Cartwright. (1990). Mesangial macromolecular uptake in captopril-treated uninephrectomized rats. Toxicology and Applied Pharmacology. 105(2). 226–233. 2 indexed citations

20.

Allen, Timothy A., et al.. (1989). Comparison of renal biopsy techniques in dogs. Journal of the American Veterinary Medical Association. 195(7). 935–939. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact